Dr Lalchandani Labs (BOM:541299) EV-to-EBIT : -79.40 (As of May. 25, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Dr Lalchandani Labs EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dr Lalchandani Labs's Enterprise Value is ₹133.72 Mil. Dr Lalchandani Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-1.68 Mil. Therefore, Dr Lalchandani Labs's EV-to-EBIT for today is -79.40.

The historical rank and industry rank for Dr Lalchandani Labs's EV-to-EBIT or its related term are showing as below:

BOM:541299' s EV-to-EBIT Range Over the Past 10 Years
Min: -81.77 Med: 6.98 Max: 28.02
Current: -79.41

During the past 11 years, the highest EV-to-EBIT of Dr Lalchandani Labs was 28.02. The lowest was -81.77. And the median was 6.98.

BOM:541299's EV-to-EBIT is ranked worse than
100% of 103 companies
in the Medical Diagnostics & Research industry
Industry Median: 21.9 vs BOM:541299: -79.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Dr Lalchandani Labs's Enterprise Value for the quarter that ended in Sep. 2023 was ₹161.93 Mil. Dr Lalchandani Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-1.68 Mil. Dr Lalchandani Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -1.04%.

Dr Lalchandani Labs EV-to-EBIT Historical Data

The historical data trend for Dr Lalchandani Labs's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Lalchandani Labs EV-to-EBIT Chart

Dr Lalchandani Labs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-EBIT

Get a 7-Day Free Trial

8.82

3.68

4.52

8.67

-22.96

Dr Lalchandani Labs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
EV-to-EBIT	Get a 7-Day Free Trial													-	8.67	-	-22.96	-

Competitive Comparison of Dr Lalchandani Labs's EV-to-EBIT

For the Diagnostics & Research subindustry, Dr Lalchandani Labs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr Lalchandani Labs's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr Lalchandani Labs's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dr Lalchandani Labs's EV-to-EBIT falls into.

Dr Lalchandani Labs EV-to-EBIT Calculation

Dr Lalchandani Labs's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	133.717	/	-1.684
	=	-79.40

Dr Lalchandani Labs's current Enterprise Value is ₹133.72 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-1.68 Mil.

Dr Lalchandani Labs (BOM:541299) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Dr Lalchandani Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 )	=	EBIT	/	Enterprise Value (Q: Sep. 2023 )
	=	-1.684	/	161.925188
	=	-1.04 %

Dr Lalchandani Labs's Enterprise Value for the quarter that ended in Sep. 2023 was ₹161.93 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Dr Lalchandani Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹-1.68 Mil.

Dr Lalchandani Labs EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Dr Lalchandani Labs's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Lalchandani Labs (BOM:541299) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr Lalchandani Labs Ltd (BOM:541299) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Greater Kailash, Part-1, M-20, Basement, South Delhi, New Delhi, IND, 110048

Website

https://www.lalchandanipathlab.com

Dr Lalchandani Labs Ltd engages in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunology, virology, cytology, and other pathological and radiological investigations. It also offers Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA, and Genetic Testing. The company operates in two segments B2B sales and B2C sales, out of which the majority is from B2C sales. Revenue is generated from the sale of services.

Dr Lalchandani Labs (BOM:541299) Headlines

No Headlines